References
- Juge PA, Granger B, Debray MP, et al. A risk score to detect subclinical rheumatoid arthritis–associated interstitial lung disease. Arthritis Rheumatol. 2022 Nov;74(11):1755–1765.
- Farquhar HJ, Beckert N, Beckert L, et al. Survival of adults with rheumatoid arthritis associated interstitial lung disease—A systematic review and meta-analysis. Semin Arthritis Rheum. 2023 Jun;60:152187.
- Idiopathic Pulmonary Fibrosis Clinical Research Network; Raghu G, Anstrom KJ, et al. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012 May 24;366(21):1968–1977.
- Solomon JJ, Danoff SK, Woodhead FA, Et al. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: A randomised, double-blind, placebo-controlled, phase 2 study. Lancet Respir Med. 2023 Jan;11(1):87–96.
- Juge PA, Wemeau L, Ottaviani S, et al. Increased mortality in patients with RA-associated interstitial lung disease: Data from a French administrative healthcare database. RMD Open. 2023 Dec 1;9(4):e003491. Erratum in: RMD Open. 2024 Jan 30;10(1):e003491corr1.
- England BR, Roul P, Mahajan TD, et al. Performance of administrative algorithms to identify interstitial lung disease in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2020 Oct;72(10):1392–1403.
- Luedders BA, Cope BJ, Hershberger D, et al. Enhancing the identification of rheumatoid arthritis-associated interstitial lung disease through text mining of chest computerized tomography reports. Semin Arthritis Rheum. 2023 Jun;60:152204.
- Maricq HR, LeRoy EC. Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy. Arthritis Rheum. 1973 Sep–Oct;16(5):619–628.
- Smith V, Herrick AL, Ingegnoli F, et al. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud’s phenomenon and systemic sclerosis. Autoimmun Rev. 2020 Mar;19(3):102458.
